UK Checklist Change Log

April 2022 Release

mTuitive have undertaken a review and update of the following checklists to ensure that they are in line with current best practice authoring, compliance with UICC and other quality checks:

  • Adult Renal Biopsy (9.1711.0.24)
  • Appendix Neoplasms-Further Investigations (9.2103.0.9)
  • Breast Core Biopsy (RC Path) (9.2108.0.51)
  • Breast Excision (RCPath) (9.2.1702.84)
  • Endometrial Biopsies Containing Carcinoma (9.1712.0.3)
  • Further Investigations Colorectal Cancer (9.1809.0.2)
  • Gastric and Oesophageal Carcinoma Biopsies (9.1910.0.2)
  • Hypopharyngeal (9.1311.0.21)
  • Lung Cancer Resection Specimens (9.1809.0.43)
  • Metastatic Carcinoma of Uncertain Primary (9.1807.0.19)
  • Molecular - CNS (RCPath) (9.2003.0.10)
  • Penile Tumours (9.1507.0.25)
  • Prostate - Biopsies (9.1606.0.31)
  • Prostate - Radical (9.1606.0.29)
  • Prostate - Transurethral Resections (9.1606.0.33)
  • Regional LN Associated with Adnexal Cell Carcinoma (9.1902.0.22)
  • Regional LN Associated with Melanoma (9.1902.0.23)
  • Regional LN Associated with Merkel Cell Carcinoma (9.1902.0.22)
  • Regional LN Associated with Squamous Cell Carcinoma (9.1902.0.25)
  • Renal Pelvis - Ureter Radical Resections (9.2108.0.42)
  • Salivary Gland (9.1311.0.21)
  • Soft Tissue Sarcomas (9.1708.0.24)
  • Testicular Cancer (Orchidectomy) (9.2020.0.47)
  • Testicular Cancer (Retroperitoneal lymph node dissections) (9.2020.0.29)
  • Thymic Epithelial Tumours (9.1710.0.42)
  • Thymic Epithelial Tumours - Biopsy (9.1710.0.14)
  • Thyroid Cancer (9.1402.1710.23)
  • Transurethral Specimens (Biopsy or TUR) (9.2108.0.36)
  • Urethrectomy or Urethral Diverticulectomy (9.2108.0.39)
  • Urinary Bladder - Cystectomy or Diverticulectomy (9.2108.0.47)
  • Uterine Sarcoma (9.1809.0.15)
  • Uveal Melanoma (9.2112.0.29)
  • Vulva - Resection (9.1801.0.25)

January 2022 Release

mTuitive have undertaken a review and update of the following checklists to ensure that they are in line with current best practice authoring, compliance with UICC and other quality checks:

  • Adult Renal Carcinoma (9.1711.1801.57)
  • Ampulla of Vater Carcinoma (9.1910.0.39)
  • Anal Canal Abdominoperineal Resection (RCPath) (9.1803.0.52)
  • Anal Canal Excisional Biopsy (RCPath) (9.1803.0.42)
  • Appendiceal Goblet Cell Adenocarcinoma (9.1910.0.34)
  • Appendiceal Mucinous Neoplasms and Adenocarcinoma (9.2103.0.36)
  • Appendiceal Neuroendocrine Tumour Resections (9.1910.0.32)
  • Bone Tumour (9.2101.0.50)
  • Cancer of Unknown Primary (RCPath) (9.1807.0.51)
  • CNS - Extra-Axial Tumours (9.2003.0.24)
  • CNS - Intra-Axial Tumours (9.2003.0.24)
  • CNS - Pituitary Tumours (9.2003.0.16)
  • Colorectal Carcinoma Local Excision Specimens (9.1809.0.40)
  • Colorectal Carcinoma Resection Specimens (9.1809.0.60)
  • Colorectal Neuroendocrine Tumour Resections (9.1910.0.43)
  • Common Bile Duct (9.1910.0.36)
  • Conjunctival Melanoma and Melanosis (9.710.1710.26)
  • Cutaneous Adnexal Cell Carcinoma (9.1902.0.47)
  • Cutaneous Basal Cell Carcinoma (9.1902.0.41)
  • Cutaneous Malignant Melanoma (9.1902.0.65)
  • Cutaneous Merkel Cell Carcinoma (9.1902.0.50)
  • Cutaneous Squamous Cell Carcinoma (9.1902.0.60)
  • Distal Urethral Tumours (9.1507.0.24)
  • Duodenal, Ampullary, Proximal Jejunal Neuroendocrine Tumour Resections (9.1910.0.33)
  • Endometrial Tumours (9.1712.0.33)
  • Gastric Carcinoma (9.1910.0.33)
  • Gastric Neuroendocrine Tumour Resections (9.1910.0.32)
  • Gastric Oesophageal Carcinoma EMR (9.1910.0.32)
  • Gastrointestinal Stromal Tumours (GISTs) (9.2001.0.25)
  • Head and Neck Lymph Nodes (9.1311.0.21)
  • Laryngeal (9.1311.0.15)
  • Liver Resection - Colorectal Cancer Metastasis (9.1206.1710.19)
  • Liver Resection - Gall Bladder Cancer (9.1206.1710.21)
  • Liver Resection - Hepatocellular Carcinoma (9.1206.1710.26)
  • Liver Resection - Intrahepatic Cholangiocarcinoma (9.1206.1710.23)
  • Liver Resection - Perihilar Cholangiocarcinoma (9.1206.1710.21)
  • Lower Jejunal and Ileal Neuroendocrine Tumour Resections (9.1910.0.42)
  • Lung Cancer Biopsy, Cytology Specimens (9.1809.0.19)
  • Lung Cancer Resection Specimens (9.1809.0.37)
  • Lymph Node Specimens for Penile or Urethral Carcinoma (9.1507.0.20)
  • Mesothelioma Biopsy, Cytology Specimens (9.1709.0.39)
  • Mesothelioma Resection Specimens (9.1709.0.34)
  • Molecular - Appendiceal Mucinous Neoplasms and Adenocarcinoma (9.2103.0.35)
  • Nasal Cavity and Paranasal Sinus (9.1311.0.22)
  • Neuroblastoma (9.1905.0.17)
  • NHSBSP Wide Bore Needle Biopsy (9.2108.0.53)
  • Ocular Retinoblastoma (9.1801.0.18)
  • Oesophageal Carcinoma (9.1910.0.31)
  • Oral Cavity (9.1311.0.32)
  • Oropharynx and Nasopharynx (9.2112.0.55)
  • Ovarian, Tubal and Primary Peritoneal Borderline Tumours (9.1907.0.41)
  • Ovarian, Tubal and Primary Peritoneal Carcinomas (9.1907.0.33)
  • Paediatric Renal Tumours (9.1811.0.23)
  • Pancreatic Carcinoma (9.1910.0.36)
  • Pancreatic Neuroendocrine Tumour Resections (9.1910.0.39)
  • Parathyroid (9.1602.0.16)
  • Penile Tumours (9.1507.0.23)
  • Phaeochromocytoma and Paraganglioma (9.1201.0.12)
  • Prostate - Biopsies (9.1606.0.28)
  • Renal Biopsy (9.1711.0.20)
  • Urinary Bladder - Cystectomy or Diverticulectomy (9.2108.0.42)
  • Uveal Melanoma (9.2112.0.28)
  • Vulva (9.1801.0.31)

December 2021 Release

  • Uveal Melanoma (9.2112.0.26) - updated to the December 2021 RCPath release
  • Vulva (9.1801.0.29) - updated for FIGO 2021

September 2021 Release

  • CNS - Extra-Axial Tumours (9.2003.0.23) - SNOMED CT code

The following checklists have been updated to the August 2021 RCPath release:

  • Axillary Core Biopsy (RCPath) (9.2108.0.19)
  • Axillary FNAC (RCPath) (9.2108.0.18)
  • Breast Core Biopsy (RC Path) (9.2108.0.49)
  • Breast FNAC (RCPath) (9.2108.0.21)
  • Breast Vacuum-Assisted Excision (9.2108.0.50)
  • NHSBSP Wide Bore Needle Biopsy (9.2108.0.51)
  • Renal Pelvis - Radical Resections (9.2108.0.34)
  • Transurethral Specimens (Biopsy or TUR) (9.2108.0.26)
  • Urethrectomy or Urethral Diverticulectomy (9.2108.0.29)
  • Urinary Bladder - Cystectomy or Diverticulectomy (9.2108.0.41)

July 2021 Release

  • Breast Excision (RCPath) (9.2.1702.78) - fixed a bug displaying hormone receptors and entering involved margins.

June 2021 Release

  • Breast Excision (RCPath) (9.2.1702.75) - additional breast excision checklist based on the standard RCPath dataset.
  • Breast Excision (9.2.1702.75) - fixed an incorrect error message when entering positive nodes in some situations.

The following checklists have updates to SNOMED CT encoding - there are no content updates.

  • Adult Renal Carcinoma (9.1711.1801.53)
  • Ampulla of Vater Carcinoma (9.1910.0.36)
  • Anal Canal Abdominoperineal Resection (RCPath) (9.1803.0.46)
  • Anal Canal Excisional Biopsy (RCPath) (9.1803.0.37)
  • Appendiceal Neuroendocrine Tumour Resections (9.1910.0.28)
  • Axillary Core Biopsy (RCPath) (9.1606.0.12)
  • Breast Biopsy (9.2.1702.39)
  • Breast Excision (9.2.1702.72)
  • Cancer of Unknown Primary (RCPath) (9.1807.0.46)
  • CNS - Extra-Axial Tumours (9.2003.0.21)
  • CNS - Intra-Axial Tumours (9.2003.0.23)
  • Colorectal Carcinoma Local Excision Specimens (9.1809.0.37)
  • Colorectal Carcinoma Resection Specimens (9.1809.0.52)
  • Colorectal Neuroendocrine Tumour Resections (9.1910.0.40)
  • Common Bile Duct (9.1910.0.34)
  • Cutaneous Adnexal Cell Carcinoma (9.1902.0.42)
  • Cutaneous Basal Cell Carcinoma (9.1902.0.38)
  • Cutaneous Malignant Melanoma (9.1902.0.57)
  • Cutaneous Merkel Cell Carcinoma (9.1902.0.46)
  • Cutaneous Squamous Cell Carcinoma (9.1902.0.57)
  • Distal Urethral Tumours (9.1507.0.22)
  • Duodenal, Ampullary, Proximal Jejunal Neuroendocrine Tumour Resections (9.1910.0.29)
  • Endometrial Tumours (9.1712.0.28)
  • Gastric Carcinoma (9.1910.0.21)
  • Gastric Neuroendocrine Tumour Resections (9.1910.0.28)
  • Gastric Oesophageal Carcinoma EMR (9.1910.0.29)
  • Lower Jejunal and Ileal Neuroendocrine Tumour Resections (9.1910.0.33)
  • Lung Cancer Biopsy, Cytology Specimens (9.1809.0.16)
  • Lung Cancer Resection Specimens (9.1809.0.35)
  • Mesothelioma Biopsy, Cytology Specimens (9.1709.0.27)
  • Neuroblastoma (9.1905.0.14)
  • Ocular Retinoblastoma (9.1801.0.16)
  • Oesophageal Carcinoma (9.1910.0.29)
  • Paediatric Renal Tumours (9.1811.0.13)
  • Pancreatic Carcinoma (9.1910.0.34)
  • Pancreatic Neuroendocrine Tumour Resections (9.1910.0.37)
  • Penile Tumours (9.1507.0.21)
  • Prostate - Biopsies (9.1606.0.22)
  • Prostate - Biopsies - Alternative (9.2012.0.34)
  • Prostate - Biopsies - MY (9.2012.0.24)
  • Prostate - Radical (9.1606.0.24)
  • Prostate - Transurethral Resections (9.1606.0.26)
  • Renal Pelvis - Radical Resections (9.1711.1801.20)
  • Testicular Cancer (Orchidectomy) (9.2020.0.42)
  • Testicular Cancer (Retroperitoneal lymph node dissections) (9.2020.0.23)
  • Thymic Epithelial Tumours (9.1710.0.36)
  • Thyroid Cancer (9.1402.1710.21)
  • Transurethral Specimens (Biopsy or TUR) (9.1304.0.18)
  • Urethrectomy or Urethral Diverticulectomy (9.1304.0.23)
  • Urinary Bladder - Cystectomy or Diverticulectomy (9.1304.0.32)
  • Uterine Sarcoma (9.1809.0.14)
  • Uveal Melanoma (9.1712.0.18)
  • Vulva (9.1801.0.28)

May 2021 Release

The following checklist updates are COSD 9 / Pathology 4 additions and corrections - there are no content updates.

  • Appendiceal Goblet Cell Adenocarcinoma (9.1910.0.31)
  • Cancer of Unknown Primary (RCPath) (9.1807.0.43)
  • Cervical Cancer in Excisional Cervical Biopsies (9.2103.0.29)
  • Cervical Cancer in Hysterectomy Specimens (9.2103.0.28)
  • CNS - Extra-Axial Tumours (9.2003.0.19)
  • CNS - Intra-Axial Tumours (9.2003.0.21)
  • CNS - Pituitary Tumours (9.2003.0.15)
  • Colorectal Carcinoma Local Excision Specimens (9.1809.0.33)
  • Colorectal Carcinoma Resection Specimens (9.1809.0.49)
  • Common Bile Duct (9.1910.0.32)
  • Conjunctival Melanoma and Melanosis (9.710.1710.22)
  • Cutaneous Adnexal Cell Carcinoma (9.1902.0.41)
  • Cutaneous Basal Cell Carcinoma (9.1902.0.34)
  • Cutaneous Merkel Cell Carcinoma (9.1902.0.45)
  • Cutaneous Squamous Cell Carcinoma (9.1902.0.53)
  • Duodenal, Ampullary, Proximal Jejunal Neuroendocrine Tumour Resections (9.1910.0.28)
  • Endometrial Tumours (9.1712.0.25)
  • Gastric Carcinoma (9.1910.0.20)
  • Gastric Neuroendocrine Tumour Resections (9.1910.0.27)
  • Gastric Oesophageal Carcinoma EMR (9.1910.0.28)
  • Gastrointestinal Stromal Tumours (GISTs) (9.2001.0.23)
  • Laryngeal (9.1311.0.12)
  • Liver Resection - Colorectal Cancer Metastasis (9.1206.1710.17)
  • Liver Resection - Gall Bladder Cancer (9.1206.1710.19)
  • Lower Jejunal and Ileal Neuroendocrine Tumour Resections (9.1910.0.32)
  • Lung Cancer Resection Specimens (9.1809.0.34)
  • Lymph Node Specimens for Penile or Urethral Carcinoma (9.1507.0.18)
  • Mesothelioma Biopsy, Cytology Specimens (9.1709.0.26)
  • Nasal Cavity and Paranasal Sinus (9.1311.0.17)
  • Neuroblastoma (9.1905.0.13)
  • Oesophageal Carcinoma (9.1910.0.28)
  • Ovarian, Tubal and Primary Peritoneal Carcinomas (9.1907.0.29)
  • Paediatric Renal Tumours (9.1811.0.12)
  • Pancreatic Carcinoma (9.1910.0.30)
  • Pancreatic Neuroendocrine Tumour Resections (9.1910.0.35)
  • Phaeochromocytoma and Paraganglioma (9.1201.0.11)
  • Prostate - Biopsies (9.1606.0.19)
  • Prostate - Biopsies - Alternative (9.2012.0.31)
  • Regional LN Associated with Adnexal Cell Carcinoma (9.1902.0.21)
  • Salivary Gland (9.1311.0.17)
  • Soft Tissue Sarcomas (9.1708.0.21)
  • Urinary Bladder - Cystectomy or Diverticulectomy (9.1304.0.31)

April 2021 Release

  • Appendiceal Neuroendocrine Tumour Resections (9.1910.0.27) - corrected Ki-67 index boundaries.
  • Bone Tumour (9.2101.0.47) - Added specify margin under Distance to other relevant bone resection margin.
  • Breast Biopsy (9.2.1702.35) - COSD 9 corrections.
  • Breast Excision (9.2.1702.65) - fixed read only 'malignant lesion disease extent' field.
  • Cervical Cancer in Excisional Cervical Biopsies (9.2103.0.27) - updated to March RCPath dataset.
  • Colorectal Neuroendocrine Tumour Resections (9.1910.0.38) - COSD 9 corrections.
  • Cutaneous Malignant Melanoma (9.1902.0.52) - COSD 9 corrections.
  • Prostate - Transurethral Resections (9.1606.0.21) - COSD 9 corrections.

March 2021 Release

As from March 2021 the only generally available release will be COSD 9 / Pathology 4.

  • Adrenal Cortical Carcinoma - no content changes, added missing COSD data element (9.1201.1710.26)
  • Bone Tumour - updated to Jan 2021 RC Path release (9.2101.0.46)
  • Breast Biopsy - no content changes, version change only (9.2.1702.32)
  • Adult Renal Carcinoma - no content changes, corrected COSD TumourNecrosisIndicator values (9.1711.1801.43)
  • Anal Canal Excisional Biopsy (RCPath) - no content changes, COSD data element updates (9.1803.0.36)
  • Anal Canal Abdominoperineal Resection (RCPath) - no content changes, COSD data element updates (9.1803.0.44)
  • Breast Excision (9.2.1702.60)
    • LCIS Subtype changed to multi-select
    • When Pleomorphic LCIS is selected, the margin field for DCIS/PLCIS will appear, even if Ductal Carcinoma In-Situ is stated to be absent.
    • Fixed receptor status field not displaying in some situations.
  • Appendiceal Mucinous Neoplasms and Adenocarcinoma - updated to March 2021 RCPath release (9.2103.0.32)
  • Molecular - Appendiceal Mucinous Neoplasms and Adenocarcinoma - updated to March 2021 RCPath release (9.2103.0.33)
  • Cervical Cancer in Hysterectomy Specimens - updated to March 2021 RCPath release (9.2103.0.27)
  • Cutaneous Squamous Cell Carcinoma - removed  "(Poorly Differentiated Component Present)" from the Grade label (9.1902.0.51)

Release 23 Feb 2021

COSD 8

  • Lung Cancer Resection - updated to RCPath release Sep 2018 (8.1809.0.32)
  • Endometrial - updated to RCPath release Dec 2017 (8.1712.0.15)

COSD 9

  • Lung Cancer Resection - updated to RCPath release Sep 2018 (9.1809.0.33)
  • Endometrial - updated to RCPath release Dec 2017 (9.1712.0.19)

Release 8 Feb 2021

COSD 8

  • Cutaneous Basal Cell Carcinoma - fixed wrong automatic lesion size (8.1902.0.28)
  • Breast Excision - fixed DCIS size missing (8.2.0.53)
  • Colorectal Carcinoma Resection Specimens -  CRM involvement changed to optional (8.1809.0.36)

COSD 9

  • Cutaneous Basal Cell Carcinoma - fixed wrong automatic lesion size (9.1902.0.32)
  • Breast Excision - fixed DCIS size missing (9.2.0.57)
  • Colorectal Carcinoma Resection Specimens -  CRM involvement changed to optional (9.1809.0.48)

Release 31 Jan 2021

COSD 8
  • Malignant Melanoma - updated to RCPath release Feb 2019 (8.1902.0.47)
  • Vulva - updated to RCPath release Jan 2018 (8.1801.0.24)
  • Pancreatic Carcinoma - updated to RC Path release Oct 2019 (8.1910.0.29)
  • Cutaneous Adnexal Cell Carcinoma - removed alert for lesion diameter (8.1902.0.34)
  • Cutaneous Basal Cell Carcinoma - removed alert for lesion diameter (8.1902.0.27)
  • Cutaneous Merkel Cell Carcinoma - removed alert for lesion diameter (8.1902.0.38)
  • Cutaneous Squamous Cell Carcinoma - removed alert for lesion diameter (8.1902.0.42)
  • Cutaneous Malignant Melanoma - removed alert for lesion diameter (8.1902.0.47)
  • Breast Excision - removed automatic calculation of DCIS, manual entry required (8.2.0.52)
  • Colorectal Carcinoma Resection Specimens -  CRM measurement changed to optional (8.1809.0.34)
COSD 9
  • Malignant Melanoma - updated to RCPath release Feb 2019 (9.1902.0.48)
  • Vulva - updated to RCPath release Jan 2018 (9.1801.0.25)
  • Pancreatic Carcinoma - updated to RC Path release Oct 2019 (9.1910.0.28)
  • Cutaneous Adnexal Cell Carcinoma - removed alert for lesion diameter (9.1902.0.39)
  • Cutaneous Basal Cell Carcinoma - removed alert for lesion diameter (9.1902.0.31)
  • Cutaneous Merkel Cell Carcinoma - removed alert for lesion diameter (9.1902.0.43)
  • Cutaneous Squamous Cell Carcinoma - removed alert for lesion diameter (9.1902.0.49)
  • Cutaneous Malignant Melanoma - removed alert for lesion diameter (9.1902.0.49)
  • Breast Excision - removed automatic calculation of DCIS, manual entry required (9.2.0.56)
  • Colorectal Carcinoma Resection Specimens -  CRM measurement changed to optional (9.1809.0.45)

Still need help? Contact Us Contact Us